Neuro-Oncology
NF2-related schwannomatosis
Dec. 13, 2024
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Mesial temporal lobe epilepsy with hippocampal sclerosis …
- Updated 03.04.2024
- Released 07.26.1994
- Expires For CME 03.04.2027
Mesial temporal lobe epilepsy with hippocampal sclerosis
Introduction
Overview
Mesial temporal lobe epilepsy is the most prevalent form of epilepsy and among the most resistant to pharmacologic treatment. Hippocampal sclerosis is a frequent pathological substrate, but other structural abnormalities in mesial temporal structures give rise to the same electroclinical syndrome. Although the etiology of hippocampal sclerosis and the natural history of mesial temporal lobe epilepsy are inadequately understood, referral to a comprehensive epilepsy center is important when seizures persist after failure of first-line medications and interference with daily living. Patients with mesial temporal lobe epilepsy often are excellent candidates for surgical treatment, with 70% to 90% becoming free of disabling seizures after treatment. Best results with respect to quality of life are obtained when surgical therapy is soon after the failure of medications.
Key points
|
• Mesial temporal lobe epilepsy with hippocampal sclerosis (TLE-HS) is a common form of epilepsy. | |
|
• Mesial temporal lobe epilepsy with hippocampal sclerosis often is progressive with worsening seizures, cognitive function, and depression. | |
|
• When medications fail to fully control seizures, resective surgery can be highly effective. |
Historical note and terminology
Hippocampal sclerosis was first identified during postmortem examination of the brains of patients with chronic epilepsy in 1825 by Bouchet and Cazauvieilh, but it was thought to be an effect rather than a cause of epileptic seizures (11). By the late 19th century, John Hughlings Jackson associated clinical ictal manifestations that we now characterize as focal seizures with impaired awareness (previously called complex partial seizures) as related to structural lesions in the mesial temporal lobe, and suggested a causal relationship (49; 50). After the introduction of the EEG, these ictal behaviors were demonstrated to be correlated with electrographic abnormality in the mesial temporal lobe (51; 51). Evidence for a causal role of hippocampal sclerosis and for the existence of a syndrome came initially from the work of Murray Falconer, who performed en bloc anterior temporal lobe resections for medication resistant temporal lobe seizures (30). As a result of careful pathological evaluation of the resected specimens, mesial temporal sclerosis was shown to be the most common substrate of this condition, and its removal resulted in a good surgical outcome (31). A workshop convened by the International League Against Epilepsy to determine if mesial temporal lobe epilepsy with hippocampal sclerosis is a syndrome or a disease concluded that it was neither and probably represents several different syndromes (101).
Clinical manifestations
Presentation and course
A characteristic clinical picture of mesial temporal lobe epilepsy with hippocampal sclerosis is well established (22; 34; 100; 103; 104; 23).
The first habitual seizures usually occur in late childhood or early adolescence and may be auras, and epilepsy often is not be identified until a seizure is bilateral tonic-clonic or a focal with impaired awareness. These impairing seizures are usually preceded by an aura, and the most common auras are visceral experiences such as nausea, butterflies, a rising epigastric sensation (34), and fear. These and other auras can occur individually or in combination. Less common auras include olfactory and gustatory hallucinations, alteration of visual perceptions (micropsia, macropsia), and distortions of memory (déjà vu, jamais vu). Some auras have no counterpart in common human experience and, therefore, are reported as indescribable. Auras can occur in isolation (focal seizures without impaired awareness, previously known as simple partial seizures), as well as in association with seizures with impairment, and patients may recall occasional auras years before they experienced the first habitual focal seizure with impairment. The focal seizure with impairment commonly begins with a motionless stare and oroalimentary automatisms (eg, lip smacking, chewing, or swallowing), during which the patient is usually, but not always, unresponsive. Gestural automatisms as well as reactive automatisms also are common ictally, postictally, or both during and after the seizure. A number of lateralizing features can occur (62; 104; 23). When dystonic posturing occurs, it is contralateral to the side of seizure onset, whereas unilateral automatisms are ipsilateral (often in combination with contralateral tonic or dystonic posturing). Head deviation early in the seizure is usually ipsilateral to the side of seizure onset, but abnormally forced head turning late in the seizure (version) is contralateral and often a prelude to bilateral tonic-clonic activity. Seizures due to mesial temporal lobe epilepsy without hippocampal sclerosis caused by parahippocampal and inferior temporal lobe structural abnormality may manifest with earlier and bilateral motor signs, which are more typically found with extratemporal lobe epilepsy (78).
Postictal dysphasia reflects seizure origin in the language dominant hemisphere and is frequently associated with a prolonged postictal state and should be differentiated from reduced interaction without an isolated language abnormality. These lateralizing findings may be less reliable in patients with bilateral independent temporal spikes (91). Patients are amnesic for the seizure and often for part of the postictal period, even though they may make semi-appropriate responses to the environment during these times, but the aura usually is remembered. Seizures less often progress to bilateral tonic-clonic when treated with antiseizure medication, and some patients never experience bilateral tonic-clonic seizures.
Seizures that are initially controlled with antiseizure medication can reappear after several years and then become medication resistant (08; 07). At this point they can occur as often as many times a week, but usually only several times a month. Precipitating factors include stress, sleep deprivation, and, in women, hormonal changes associated with the menstrual cycle.
Neurologic examination is usually normal apart from memory deficits, which are material-specific for the side of hippocampal sclerosis, and possibly also social cognitive dysfunction (86; 10). Memory dysfunction can worsen when seizures are frequent and may improve when seizures are controlled. The presence of hippocampal sclerosis is associated with an approximately doubled rate of depression in mesial temporal lobe epilepsy (15). Whether it is associated with a higher incidence of behavioral disturbances, including depression and psychosis, than other forms of epilepsy remains uncertain (24; 55).
Clinical vignette
This 29-year-old, right-handed woman had a prolonged febrile seizure with predominantly right-sided convulsive movements when 9 months old. Immediately following the convulsion, she was noted to have right-sided weakness that resolved over 12 hours. She remained well until 14 years old, when she experienced a peculiar olfactory experience, lost consciousness, and began to salivate profusely. She then had a bilateral tonic-clonic seizure. An antiseizure medication was started, and bilateral tonic-clonic seizures were controlled; however, focal seizures with impaired awareness persisted at a frequency of 4 to 15 monthly and had perimenstrual clustering. Seizures consistently began with a peculiar olfactory hallucination that she could not describe. After the hallucination, she lost consciousness and exhibited semipurposeful activity.
Because seizures continued to be poorly controlled despite treatments with a variety of antiseizure medications, alone and in combination, she was evaluated for epilepsy surgery. Her MRI had findings compatible with left hippocampal sclerosis.
Neuropsychological testing revealed normal intelligence and a profile consistent with left temporal lobe dysfunction. During scalp video-EEG monitoring, left anterior to mid temporal sharp wave discharges were recorded. Four seizures also were recorded, and they began with her typical aura with subsequent impaired interaction and staring. Her right hand and arm developed dystonic posturing, and the left hand performed purposeless, repetitive movements. If the seizure continued, she had extreme right head turning followed by bilateral tonic-clonic activity. The EEG during the seizures revealed consistent but delayed left temporal seizure onset and evolution. The intracarotid amobarbital test demonstrated left hemisphere speech, absent left hemisphere memory function, and intact right hemisphere memory function.
She underwent a left selective amygdalohippocampectomy. Pathology examination revealed typical mesial temporal sclerosis. In the 6 years since surgery, no additional seizures have occurred. She is currently taking no antiseizure medications.
Comment. This case is an almost classic example of mesial temporal lobe epilepsy. The history and findings at evaluation contain many of the components noted in the generic description of the condition.
Biological basis
Etiology and pathogenesis
Hippocampal sclerosis is the most common pathological substrate of mesial temporal lobe epilepsy, but other structural abnormalities within the anterior-mesial temporal lobe anatomic region also may be present with mesial temporal lobe epilepsy. These abnormalities may be due to numerous types of lesions, including malformations of development such as cortical dysplasia, vascular abnormalities such as a cavernous malformation, hamartia, and encephalomalacia such as from a cerebral infection (37). A combination of hippocampal sclerosis and another abnormality has been termed "dual pathology” (70), and about a third of patients with hippocampal sclerosis have dual pathology with the second abnormality almost always ipsilateral to the hippocampal sclerosis (48). Overall, the location(s) of the structural abnormality or abnormalities impact the clinical manifestation, so they may be considered to produce subtypes of mesial temporal lobe epilepsy (54).
Hippocampal sclerosis consists of hippocampal neuronal loss in a characteristic pattern, predominantly involving the hilar region, CA1, and dentate gyrus, with relative sparing of CA2 (02). The cause of hippocampal sclerosis is unknown. There is a high incidence of complicated febrile convulsions among patients with hippocampal sclerosis (31; 34; 74), and patients without this history often have had other cerebral injuries early in life (75; 80), suggesting a causative role of these events. Uncontrolled inflammation related to seizures and due to infection, trauma, or other environmental insult has been postulated (95; 106; 96; 01). However, specific infections, cytokines, and antibodies also are now being considered as possibilities for at least a small percentage of patients (57; 97; 69; 79). Although controversial, there is increasing evidence of progression of the epileptogenic process (06; 75; 93). A familial form of mesial temporal lobe epilepsy has been described, and some of these patients develop medically intractable seizures and hippocampal sclerosis (16).
Hippocampal sclerosis consists of selective neuronal cell loss in specific subfields, with particular susceptibility of somatostatin and neuropeptide Y-containing hilar neurons (19; 76). Surviving neurons can show abnormalities consisting of loss of dendritic spines, beading of dendritic processes, and reduction in the dendritic domain. Sprouting of dentate granule cell axons (mossy fibers) has been demonstrated, with terminals extending back to the proximal fields of granule cell dendrites (94), presumably producing monosynaptic recurrent excitatory circuits. Although several other disturbances have been described in human sclerotic hippocampus (05; 13; 20), there is no overall reduction in GABA-containing inhibitory interneurons or their terminals, and it is likely that sprouting and abnormal synaptic reorganization involve other hippocampal neuronal populations, both excitatory and inhibitory (03). Enhanced sensitivity to glutamate may also be an important part of the pathophysiology of medial temporal lobe epilepsy (12). Studies in experimental animal models have demonstrated the appearance of abnormal NMDA receptor-mediated excitation, whereas both animal and human studies suggest enhanced inhibition, at least in the interictal state. These changes could predispose surviving hippocampal neurons to abnormal hypersynchronous discharges that develop in small clusters and coalesce to produce propagation to other limbic and nonlimbic structures, producing the manifestations of focal seizures (21; 99). Investigations are now including transcriptomics, proteomics, metabolomics, and epigenomics with emerging abnormalities (14).
Although one hippocampus is predominantly involved in most patients, there is usually evidence of contralateral hippocampal epileptiform disturbances as well as both functional and structural extrahippocampal abnormalities (60). The epileptogenic region must extend beyond one mesial temporal area because occasionally patients continue to have their habitual auras following otherwise successful anterior temporal lobe resection. The full extent of the epileptogenic region is not known; however, it is likely to include the thalamus, the posterior cingulate, and precuneus (59; 71). Resting-state (interictal) functional MRI on a group-level has identified functional connectivity abnormalities between hippocampi in unilateral mesial temporal lobe epilepsy and within regions of the frontal and parietal lobes (83; 39; 84; 40). Complementing this, group-level, extratemporal white matter network abnormalities have been identified in bilateral frontal and parietal lobes (88; 72; 107). Overall, advanced structural and functional imaging investigations have further supported the understanding of mesial temporal lobe epilepsy as a condition that extends across a network of brain regions with multiple hubs between the abnormal connections (17; 53).
Epidemiology
Focal seizures are the most common seizure type, and 40% of patients report focal seizures with impairment (36). Not all focal seizures with impaired awareness, however, are of mesial temporal lobe origin. Approximately 40% of these seizures originate elsewhere (23). In one study, half of patients seen in an epilepsy outpatient clinic had a diagnosis of temporal lobe epilepsy, and half of these had evidence of hippocampal sclerosis on MRI (90). Of patients whose epileptogenic region is sufficiently well localized to one temporal lobe to warrant temporal resection, 60% to 70% have hippocampal sclerosis (02). The others have small alien tissue lesions such as hamartomas or glial tumors, vascular and congenital malformations, and nonspecific findings.
Prevention
Mesial temporal lobe epilepsy is associated with a high incidence of complicated febrile convulsions and specific cerebral injuries, such as infection and trauma, usually before 5 years of age (75). Birth trauma does not appear to be an important risk factor.
Differential diagnosis
Confusing conditions
Focal seizures with impaired awareness can be produced by many brain areas. Furthermore, not all mesial temporal onset seizures are due to hippocampal sclerosis. No definitive characteristics distinguish focal seizures reflecting mesial temporal lobe epilepsy from focal seizures generated from neocortex or due to mesial temporal lesions other than hippocampal sclerosis (82). However, mesial temporal lobe epilepsy is not likely to be the diagnosis when seizures are brief and frequent; involve early focal motor, somatosensory, visual or auditory signs and symptoms, drop attacks, or consistently become bilateral tonic-clonic; there are associated neurologic or cognitive impairments other than memory loss; or there are interictal epileptiform EEG findings that are extratemporal or bilaterally synchronous (22; 100; 23; 23). There are, however, exceptions. Temporal lobe seizures that become medically refractory before the age of 12 years are relatively unlikely to be due to hippocampal sclerosis (105), although mesial temporal lobe epilepsy is historically underdiagnosed in children (41). Definitive diagnosis requires pathological evidence of hippocampal sclerosis or other mesial temporal lesions, with improvement of the epileptic condition following surgical removal. In patients with the typical clinical features, diagnosis can be made with a high degree of confidence by demonstration of co-lateralized hippocampal atrophy and increased T2-weighted or FLAIR signal on MRI (66; 64), anterior temporal ictal EEG onset, and temporal hypometabolism with interictal PET (21). Sensitivity for diagnosing mesial temporal lobe epilepsy may be enhanced with other PET tracers (44). Ictal SPECT also exhibits a characteristic pattern for mesial temporal lobe epilepsy (58).
Diagnostic workup
Interictal EEG findings in patients with mesial temporal lobe epilepsy typically include unilateral or bilaterally-independent anterior temporal epileptiform discharges, best seen with basal (cheek, sphenoidal, earlobe, or true temporal) derivations. Regional temporal interictal slowing is seen in about half of the patients and is of lateralizing value (63). High-resolution MRI often demonstrates hippocampal atrophy with abnormal signal intensity and blurring of the hippocampal anatomy on one side (67). The ipsilateral temporal pole is often abnormal, as evident in signal abnormality and blurring of the gray-white junction (85). The same temporal lobe is hypometabolic on interictal FDG-PET (21; 38). Although interictal SPECT will often reveal an area of temporal hypoperfusion, the yield is low and not as reliable as PET hypometabolism; however, SPECT is valuable when demonstrating hyperperfusion as an ictal finding (47). Proton magnetic resonance spectroscopy can demonstrate decreased N-acetylaspartate in the sclerotic mesial temporal lobe (46; 65). Neuropsychological evaluation commonly demonstrates memory dysfunction, which is material-specific to the involved hemisphere and has been related to the degree of hippocampal cell loss (81; 45). Ictal video-EEG recordings usually reveal a stereotyped ictal behavior and a characteristic ictal EEG onset consisting of rhythmic 5- to 7-Hz activity over one temporal lobe, either as the first electrographic change (initial focal onset) or within 30 seconds (delayed focal onset) (87). The presence of more than one stereotyped ictal behavior raises the likelihood that bilateral temporal lobe epilepsy may be present (73). Although diagnosis of mesial temporal lobe epilepsy and identification of the side of ictal onset for surgical therapy is now usually achievable in most patients using noninvasive tests, when side of mesial temporal ictal onset is unclear, or there remains a possibility of neocortical ictal onset, additional long-term monitoring with intracranial electrodes is appropriate. Stereotactically placed depth electrodes are useful for this purpose, but subdural strips or grids and foramen ovale electrodes can also be used, alone or in combination with depth electrodes (92).
Management
All of the antiseizure medications that have demonstrated efficacy for focal-onset (partial) seizures may be considered as potentially efficacious for mesial temporal lobe epilepsy (33). Prolonged trials of multiple drugs are not recommended in surgically remediable conditions because of the higher success rate of resection (23). Because of the psychosocial consequences of disabling epilepsy in adolescence and early adulthood, patients who may have mesial temporal lobe epilepsy should be referred to epilepsy centers as soon as it is apparent that control cannot be achieved with first-line medications. These patients are excellent candidates for surgical treatment, and the evaluation can usually be performed noninvasively. When candidacy is present, an anterior temporal lobe resection can abolish disabling seizures in 70% to 90% of patients with low complication rates (23; 68; 26; 77), and seizure freedom at 18 years after surgery has been reported to be 62% (43). Gamma knife surgery, stereotactic laser or radiofrequency thermoablation, and direct brain stimulation of one of several described targets are possible alternative treatments to resective surgery, but the results of these other techniques are not established to have equivalently high success rates (04; 09; 29; 42; 56; 32; 18; 98). Vagus nerve stimulation is an alternative treatment when resective surgical therapy is not possible, but it rarely produces seizure freedom (89). Psychosocial intervention is also important in the management of many patients with mesial temporal lobe epilepsy, and it is particularly important for rehabilitation following successful surgery. The quality of life following surgical treatment depends on psychosocial factors such as family support and preexisting vocational and interpersonal skills, as well as age at surgical intervention.
Outcomes
The natural history of mesial temporal lobe epilepsy is not known because only patients with medically intractable seizures undergo surgical resection where the definitive pathological diagnosis can be made (07).
When seizures become refractory to medical treatment they are unlikely to remit spontaneously. If the condition continues, increasing memory problems and other comorbidities have been reported, including autonomic dysfunction (23; 61). This sequence of events suggests that mesial temporal lobe epilepsy could be a progressive epileptic disorder. There is also an elevated morbidity and mortality rate in patients with uncontrolled seizures (93). With early surgical intervention, patients with mesial temporal lobe epilepsy with hippocampal sclerosis have an excellent chance of cure and a subsequent normal life, and the surgical success likelihood is independent to the histopathologic subtype of hippocampal sclerosis (35).
Special considerations
Pregnancy
Although no information is available that is specific to this condition and pregnancy, general information about epilepsy and pregnancy is relevant.
Media
References
- 01
- Aulicka S, Ceska K, Sana J, et al. Cytokine-chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Epilepsy Res 2022;180:106858. PMID 35026708
- 02
- Babb TL, Brown WJ. Pathological findings in epilepsy. In: Engel J Jr, editor. Surgical Treatment of the Epilepsies. New York: Raven, 1987:51140.
- 03
- Babb TL, Pretorius JK, Mello LE, Mathern GW, Levesque MF. Synaptic reorganizations in epileptic human and rat kainate hippocampus may contribute to feedback and feedforward excitation. Epilepsy Research 1992;(Suppl 9):193-203. PMID 1337439
- 04
- Bartolomei F, Hayashi M, Tamura M, et al. Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsy. Neurology 2008;70(19):1658-63. PMID 18401026
- 05
- Bayer TA, Wiestler OD, Wolf HK. Hippocampal loss of N-methyl-D-aspartate receptor subunit 1 mRNA in chronic temporal lobe epilepsy. Acta Neuropathol 1995;89:446-50. PMID 7618442
- 06
- Beach TG, Woodhurst WB, MacDonald DB, Jones MW. Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy. Neurosci Lett 1995;191:27-30. PMID 7659283
- 07
- Berg AT. The natural history of mesial temporal lobe epilepsy. Curr Opin Neurol 2008;21(2):173-8. PMID 18317276
- 08
- Berg AT, Langfitt J, Shinnar S, et al. How long does it take for partial epilepsy to become intractable. Neurology 2003;60(2):186-90. PMID 12552028
- 09
- Boex C, Seeck M, Vulliemoz S, et al. Chronic deep brain stimulation in mesial temporal lobe epilepsy. Seizure 2011;20(6):485-90. PMID 21489828
- 10
- Bora E, Meletti S. Social cognition in temporal lobe epilepsy: a systematic review and meta-analysis. Epilepsy Behav 2016;60:50-7. PMID 27179192
- 11
- Bouchet C, Cazauvieilh JB. De l'épilepsie considéré dans ses rapports avec l'aliénation mentale. Arch Gen Med 1825;9:510-42.
- 12
- Brines ML, Sundaresan S, Spencer DD, deLanerolle NC. Quantitative autoradiographic analysis of ionotropic glutamate receptor subtypes in human temporal lobe epilepsy: up-regulation in reorganized epileptogenic hippocampus. Eur J Neurosci 1997;9(10):2035-44. PMID 9421164
- 13
- Brines ML, Tabuteau H, Sundaresan S, Kim J, Spencer DD, de Lanerolle N. Regional distributions of hippocampal Na+,K+-ATPase, cytochrome oxidase, and total protein in temporal lobe epilepsy. Epilepsia 1995;36:371-83. PMID 7607116
- 14
- Bruxel EM, Bruno DCF, do Canto AM, et al. Multi-omics in mesial temporal lobe epilepsy with hippocampal sclerosis: Clues into the underlying mechanisms leading to disease. Seizure 2021;90:34-50. PMID 33722437
- 15
- Cai L, He Q, Luo H, et al. Is depression in patients with temporal lobe epilepsy related to hippocampal sclerosis? A meta-analysis. Clin Neurology Neurosurg 2023;225:107602. PMID 36689793
- 16
- Cendes F, Lopes-Cendes I, Andermann E, Andermann F. Familial temporal lobe epilepsy: a clinically heterogeneous syndrome. Neurology 1998;50(2):554-7. PMID 9484399
- 17
- Chiang S, Stern JM, Engel J Jr, Haneef Z. Structural-functional coupling changes in temporal lobe epilepsy. Brain Res 2015;1616:45-57. PMID 25960346
- 18
- Cukiert A, Cukiert CM, Burattini JA, Mariani PP. Long-term seizure outcome during continuous bipolar hippocampal deep brain stimulation in patients with temporal lobe epilepsy with or without mesial temporal sclerosis: An observational, open-label study. Epilepsia 2021;62(1):190-7. PMID 33258105
- 19
- de Lanerolle NC, Brines ML, Kim JH, Williamson A, Philips MF, Spencer DD. Neurochemical remodeling of the hippocampus in human temporal lobe epilepsy. Epilepsy Research 1992;(Suppl 9):205-20. PMID 1363041
- 20
- de Lanerolle NC, Gunel M, Sundaresan S, Shen MY, Brines ML, Spencer DD. Vasoactive intestinal polypeptide and its receptor changes in human temporal lobe epilepsy. Brain Res 1995;686:182-93. PMID 7583284
- 21
- Engel J Jr. Functional explorations of the human epileptic brain and their therapeutic implications. Electroencephalogr Clin Neurophysiol 1990;76:296-316. PMID 1699723
- 22
- Engel J Jr. Recent advances in surgical treatment of temporal lobe epilepsy. Acta Neurol Scand 1992;86(Suppl 5):71-80. PMID 1441912
- 23
- Engel J Jr. Surgical treatment for epilepsy: too little too late. JAMA 2008;300(21):2548-50. PMID 19050199
- 24
- Engel J Jr, Bandler R, Griffith NC, Caldecott-Hazard S. Neurobiological evidence for epilepsy-induced interictal disturbances. In: Smith D, Treiman D, Trimble M, editors. Advances in Neurology. Vol. 55. New York: Raven, 1991:97-111.
- 25
- Engel J Jr, Henry T, Risinger MW, et al. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology 1990;40:1670-7. PMID 2122275
- 26
- Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 2012;307(9):922-30. PMID 22396514
- 27
- Engel J Jr, Williamson PD. Limbic seizures. In: Engel J Jr, Pedley TA, editors. Epilepsy: A Comprehensive Textbook, 2nd ed. Philadelphia: Lippincott-Raven, 2008:541-52.
- 28
- Engel J Jr, Williamson PD, Wieser HG. Mesial temporal lobe epilepsy with hippocampal sclerosis. In: Engel J Jr, Pedley TA, editors. Epilepsy: A Comprehensive Textbook, 2nd ed. Philadelphia: Lippincott-Raven, 2008:2479-86.
- 29
- Esquenazi Y, Kalamangalam GP, Slater JD, et al. Stereotactic laser ablation of epileptogenic periventricular nodular heterotopia. Epilepsy Res 2014;108(3):547-54. PMID 24518890
- 30
- Falconer MA. Discussion on the surgery of temporal lobe epilepsy: surgical and pathological aspects. Proc R Soc Med 1953;46:971-4.
- 31
- Falconer MA. Genetic and related aetiological factors in temporal lobe epilepsy: a review. Epilepsia 1971;12:13-31. PMID 5282880
- 32
- Fan X, Shan Y, Lu C, et al. Optimized SEEG-guided radiofrequency thermocoagulation for mesial temporal lobe epilepsy with hippocampal sclerosis. Seizure 2019;71:304-11. PMID 31521052
- 33
- French JA, Pedley TA. Clinical practice. Initial management of epilepsy. N Engl J Med 2008;359(2):166-76. PMID 18614784
- 34
- French JA, Williamson PD, Thadani VM, et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 1993;34:774-80. PMID 8250525
- 35
- Gales JM, Jehi L, Nowacki A, Prayson RA. The role of histopathologic subtype in the setting of hippocampal sclerosis-associated mesial temporal lobe epilepsy. Hum Pathol 2017;63:79-88. PMID 28322853
- 36
- Gastaut H, Gastaut JL, Goncalves e Silva GE, Fernandez Sanchez GR. Relative frequency of different types of epilepsy: a study employing the classification of the International League Against Epilepsy. Epilepsia 1975;16:457-61. PMID 1183420
- 37
- Gawelek KL, Gales JM, Prayson RA. Hamartia in hippocampal sclerosis-associated mesial temporal lobe epilepsy. Ann Diagn Pathol 2018;32:63-66. PMID 28888331
- 38
- Hajek M, Antonini A, Leenders KL, Wieser HG. Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography. Neurology 1993;43:79-86. PMID 8423915
- 39
- Haneef Z, Lenartowicz A, Yeh HJ, Engel J, Stern JM. Effect of lateralized temporal lobe epilepsy on the default mode network. Epilepsy Behav 2012;25(3):350-7. PMID 23103309
- 40
- Haneef Z, Lenartowicz A, Yeh HJ, Levin HS, Engel J, Stern JM. Functional connectivity of hippocampal networks in temporal lobe epilepsy. Epilepsia 2014;55(1):137-45. PMID 24313597
- 41
- Harvey AS, Grattan-Smith JD, Desmond PM, Chow CW, Berkovic SF. Febrile seizures and hippocampal sclerosis: frequent and related findings in intractable temporal lobe epilepsy of childhood. Pediatr Neurol 1995;12:201-6. PMID 7619185
- 42
- Heck CN, King-Stephens D, Massey AD, et al. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial. Epilepsia 2014;55(3):432-41. PMID 24621228
- 43
- Hemb M, Palmini A, Paglioli E, et al. An 18-year follow-up of seizure outcome after surgery for temporal lobe epilepsy and hippocampal sclerosis. J Neurol Neurosurg Psychiatry 2013;84(7):800-5. PMID 23408065
- 44
- Henry TR, Chugani HT. Positron emission tomography. In: Engel J Jr, Pedley TA, editors. Epilepsy: A Comprehensive Textbook, 2nd Ed. Philadelphia: Lippincott-Raven, 2008:945-64.
- 45
- Hermann BP, Seidenberg M, Schoenfeld J, Davies K. Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy (see comments). Arch Neurol 1998;55(5):754.
- 46
- Hetherington H, Kuzniecky R, Pan J, et al. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol 1995;38:396-404. PMID 7668825
- 47
- Ho SS, Berkovic SF, McKay WJ, Kalnins RM, Bladin PF. Temporal lobe epilepsy subtypes: differential patterns of cerebral perfusion on ictal SPECT. Epilepsia 1996;37:788-95. PMID 8764820
- 48
- Hofman PA, Fitt G, Mitchell LA, Jackson GD. Hippocampal sclerosis and a second focal lesion. How often is it ipsilateral. Epilepsia 2011;52:718-21. PMID 21426330
- 49
- Jackson JH. On a particular variety of epilepsy ("intellectual aura"), one case with symptoms of organic brain disease. Brain 1880;11:179-207.
- 50
- Jackson JH, Colman WS. Case of epilepsy with tasting movements and "dreaming state"—very small patch of softening in the left uncinate gyrus. Brain 1898;21:580-90.
- 51
- Jasper HH. Electroencephalography. In: Penfield W, Erickson TC, editors. Epilepsy and Cerebral Localization. Springfield, Ill: Charles C. Thomas, 1941:380-454.
- 52
- Jasper H, Kershman J. Electroencephalographic classification of the epilepsies. Arch Neurol Psychiatry 1941;45:903-43.
- 53
- Jin SH, Jeong W, Chung CK. Mesial temporal lobe epilepsy with hippocampal sclerosis is a network disorder with altered cortical hubs. Epilepsia 2015;56(5):772-9. PMID 25809843
- 54
- Kahane P, Bartolomei F. Temporal lobe epilepsy and hippocampal sclerosis: lessons from depth EEG recordings. Epilepsia 2010;51 Suppl1:59-62. PMID 20331718
- 55
- Kanemoto K, Takeuchi J, Kawasaki J, Kawai I. Characteristics of temporal lobe epilepsy with mesial temporal sclerosis, with special reference to psychotic episodes. Neurology 1996;47:1199-203. PMID 8909430
- 56
- Kang JY, Wu C, Tracy J, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia 2016;57(2):325-34. PMID 26697969
- 57
- Kawamura Y, Nakayama A, Kato T, et al. Pathogenic role of human herpes virus 6B infection in mesial temporal lobe epilepsy. J Infect Dis 2015;212(7):1014-21. PMID 25840441
- 58
- Kazemi NJ, O’Brien TJ, Cascino GD, So EL. Single photon emission computed tomography. In: Engel J Jr, Pedley TA, editors. Epilepsy: A Comprehensive Textbook, 2nd ed. Philadelphia: Lippincott-Raven, 2008:965-73.
- 59
- Kim CH, Koo B-B, Chung CK, et al. Thalamic changes in temporal lobe epilepsy with and without hippocampal sclerosis: a diffusion tensor imaging study. Epilepsy Res 2010;90:21-7. PMID 20307957
- 60
- Koepp MJ, Labbe C, Richardson MP, et al. Regional hippocampal (11C) flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997;120(10):1865-76. PMID 9365376
- 61
- Koseoglu E, Kucuk S, Arman F, Ersoy AO. Factors that affect interictal cardiovascular autonomic dysfunction in temporal lobe epilepsy: role of hippocampal sclerosis. Epilepsy Behav 2009;16(4):617-21. PMID 19854109
- 62
- Kotagal P, Luders H, Morris HH, et al. Dystonic posturing in complex partial seizures of temporal lobe onset: a new lateralizing sign. Neurology 1989;39:196-201. PMID 2915789
- 63
- Koutroumanidis M, Binnie CD, Elwes RD, et al. Interictal regional slow activity in temporal lobe epilepsy correlates with lateral temporal hypometabolism as imaged with 18FDG PET: neurophysiological and metabolic implications. J Neurol Neurosurg Psychiatry 1998;65(2):170-6. PMID 9703166
- 64
- Kuzniecky R, Billir E, Faught E, Palmer C, Morawetz R, Jackson G. Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology 1997;49(3):774-8. PMID 9305339
- 65
- Kuzniecky R, Hugg JW, Hetherington H, et al. Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 1998;51(1):66-71. PMID 9674780
- 66
- Kuzniecky RI, Jackson GD. Magnetic resonance in epilepsy. New York: Raven Press, 1995.
- 67
- Labate A, Gambardella A, Aguglia U, et al. Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study. Neurology 2010;74(7):553-7. PMID 20089943
- 68
- Langfitt JT, Wiebe S. Early surgical treatment for epilepsy. Curr Opin Neurol 2008;21(2):179-83. PMID 18317277
- 69
- Leal B, Chaves J, Carvalho C, et al. Immunogenetic predisposing factors for mesial temporal lobe epilepsy with hippocampal sclerosis. Int J Neurosci 2018;128(4):305-10. PMID 28675059
- 70
- Levesque MF, Nakasato N, Vinters HV, Babb TL. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg 1991;75:364-70. PMID 1869934
- 71
- Liao W, Zhang Z, Pan Z, et al. Default mode network in mesial temporal lobe epilepsy: a study combining fMRI and DTI. Hum Brain Mapp 2011;32:883-95. PMID 20533558
- 72
- Liu M, Chen Z, Beaulieu C, Gross DW. Disrupted anatomic white matter network in left mesial temporal lobe epilepsy. Epilepsia 2014;55(5):674-82. PMID 24650167
- 73
- Loesch AM, Feddersen B, Tezer FI, et al. Seizure semiology identifies patients with bilateral temporal lobe epilepsy. Epilepsy Res 2015;109:197-202. PMID 25524859
- 74
- Maher J, McLachlan RS. Febrile convulsions. Is seizure duration the most important predictor of temporal lobe epilepsy. Brain 1995;118:1521-8. PMID 8595481
- 75
- Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 1995;118:105-18. PMID 7894997
- 76
- Mathern GW, Wilson CL, Beck H. Hippocampal sclerosis. In: Engel J Jr, Pedley TA, editors. Epilepsy: A Comprehensive Textbook, 2nd ed. Philadelphia: Lippincott-Raven, 2008:121-36.
- 77
- Mathon B, Navarro V, Bielle F, et al. Complications after surgery for mesial temporal lobe epilepsy associated with hippocampal sclerosis. World Neurosurg 2017;102:639-50. PMID 28389411
- 78
- Mirandola L, Badawy RA, Saunders AM, McIntosh A, Berkovic SF, Jackson GD. Clinical features of seizures associated with parahippocampal/inferior temporal lesions compared to those with hippocampal sclerosis. Epilepsia 2010;51(9):1906-9. PMID 20345936
- 79
- Nobrega AW, Gregory CP, Schlindwein-Zanini R, et al. Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies. Epilepsia 2018;59(9):e152-6. PMID 30146688
- 80
- O'Connor WM, Masukawa L, Freese A, Sperling MR, French JA, O'Connor MJ. Hippocampal cell distributions in temporal lobe epilepsy: a comparison between patients with and without an early risk factor. Epilepsia 1996;37:440-9. PMID 8617172
- 81
- O'Rourke DM, Saykin AJ, Gilhool JJ, Harley R, O'Connor MJ, Sperling MR. Unilateral hemispheric memory and hippocampal neuronal density in temporal lobe epilepsy. Neurosurgery 1993;32:574-80. PMID 8474648
- 82
- Pacia SV, Devinsky O, Perrine K, et al. Clinical features of neocortical temporal lobe epilepsy. Ann Neurol 1996;40:724-30. PMID 8957013
- 83
- Pereira FR, Alessio A, Sercheli MS, et al. Asymmetrical hippocampal connectivity in mesial temporal lobe epilepsy: evidence from resting state fMRI. BMC Neurosci 2010;11:66. PMID 20525202
- 84
- Pittau F, Grova C, Moeller F, Dubeau F, Gotman J. Patterns of altered functional connectivity in mesial temporal lobe epilepsy. Epilepsia 2012;53(6):1013-23. PMID 22578020
- 85
- Prado CAC, Federico P, Bernasconi A, et al. Imaging characteristics of temporalopolar blurring in the context of hippocampal sclerosis. Epileptic Disord 2022;24(1):1-8. PMID 34796882
- 86
- Rausch R. Psychological evaluation. In: Engel J Jr, editor. Surgical Treatment of the Epilepsies. New York: Raven, 1987:181-95.
- 87
- Risinger MW, Engel J Jr, Van Ness PC, Henry TR, Crandall PH. Ictal localization of temporal lobe seizures with scalp/sphenoidal recordings. Neurology 1989;39:1288-93. PMID 2797451
- 88
- Scanlon C, Mueller SG, Cheong I, Hartig M, Weiner MW, Laxer KD. Grey and white matter abnormalities in temporal lobe epilepsy with and without mesial temporal sclerosis. J Neurol 2013;260(9):2320-9. PMID 23754695
- 89
- Schachter SC, Boon P. Vagus nerve stimulation. In: Engel J Jr, Pedley TA, editors. Epilepsy: A Comprehensive Textbook, 2nd Ed. Philadelphia: Lippincott-Raven, 2008:1395-9.
- 90
- Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence. Neurology 1998;51(5):1256-62. PMID 9818842
- 91
- Serles W, Pataraia E, Bacher J, et al. Clinical seizure lateralization in mesial temporal lobe epilepsy: differences between patients with unitemporal interictal spikes. Neurology 1998;50(3):742-7. PMID 9521267
- 92
- Spencer SS, Sperling MR, Shewmon DA, Kahane P. Intracranial electrodes. In: Engel J Jr, Pedley TA, editors. Epilepsy: A Comprehensive Textbook, 2nd ed. Philadelphia: Lippincott-Raven, 2008:1791-1815.
- 93
- Sperling MR. The consequences of uncontrolled epilepsy. CNS Spectr 2004;9(2):98-109. PMID 14999166
- 94
- Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321-30. PMID 2508534
- 95
- Theodore WH, Epstein L, Gaillard WD, Shinnar S, Wainwright MS, Jacobson S. Human herpes virus 6B: a possible role in epilepsy. Epilepsia 2008;49(11)1828-37. PMID 18627418
- 96
- Uludag IF, Duksal T, Tiftikcioglu BI, Zorlu Y, Ozkaya F, Kirkali G. IL-1B, IL-6 and IL1Ra levels in temporal lobe epilepsy. Seizure 2015;26:22-5. PMID 25799897
- 97
- Vanli-Yavuz EN, Erdag E, Tuzun E, et al. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry 2016;87(7):684-92. PMID 27151964
- 98
- Vazquez-Barron D, Cuellar-Herrera M, Velasco F, Velasco AL. Electrical stimulation of subiculum for the treatment of refractory mesial temporal lobe pielpsy with hippocampal sclerosis: A 2-year follow-up study. Stereotact Funct Neurosurg 2021;99(1):40-7. PMID 33113540
- 99
- Weiss SA, Alvarado-Rojas C, Bragin A, et al. Ictal onset patterns of local field potentials, high frequency oscillations, and unit activity in human mesial temporal lobe epilepsy. Epilepsia 2016;57(1):111-21. PMID 26611159
- 100
- Wieser HG, Engel J Jr, Williamson PD, Babb TL, Gloor P. Surgically remediable temporal lobe syndromes. In: Engel J Jr, editor. Surgical Treatment of the Epilepsies. 2nd ed. New York: Raven, 1993:49-63.
- 101
- Wieser HG; ILAE Commission on Neurosurgery in Epilepsy. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004;45(6):695-714. PMID 15144438
- 102
- Williamson PD, Engel J Jr. Anatomic classification of focal epilepsies. In: Engel J Jr, Pedley TA, editors. Epilepsy: A Comprehensive Textbook, 2nd ed. Philadelphia: Lippincott-Raven, 2008:2465-77.
- 103
- Williamson PD, French JA, Thadani VM, et al. Characteristics of medial temporal lobe epilepsy: II. Interictal and ictal scalp electroencephalopathy, neuropsychological testing, neuroimaging, surgical results and pathology. Ann Neurol 1993;34:781-7. PMID 8250526
- 104
- Williamson PD, Thadani VM, French JA, et al. Medial temporal lobe epilepsy: videotape analysis of objective clinical seizure characteristics. Epilepsia 1998;39(11):1182-8. PMID 9821982
- 105
- Wyllie E, Chee M, Granstrom ML, et al. Temporal lobe epilepsy in early childhood. Epilepsia 1993;34:859-68. PMID 8404738
- 106
- Yang T, Zhou D, Stefan H. Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression. J Neurol Sci 2010;296:1-6. PMID 20663517
- 107
- Zanao TA, Lopes TM, de Campos BM, Yasuda CL, Cendes F. Patterns of default mode network in temporal lobe epilepsy with and without hippocampal sclerosis. Epilepsy Behav 2021;121(Pt B):106523. PMID 31645315
Contributors
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Author
-
John M Stern MD
Dr. Stern, Director of the Epilepsy Clinical Program at the University of California in Los Angeles, received honorariums from Ceribell, Jazz, LivaNova, Neurelis, SK Life Sciences, Sunovian, and UCB Pharma as advisor and/or lecturer.
See Profile
Editor
-
Jerome Engel Jr MD PhD
Dr. Engel of the David Geffen School of Medicine at the University of California, Los Angeles, has no relevant financial relationships to disclose.
See Profile
Former Authors
- Peter D Williamson MD
Patient Profile
- Age range of presentation
-
- 2 to 65+ years
- Sex preponderance
-
- male=female
- Heredity
-
- heredity may be a factor
- Population groups selectively affected
-
- none selectively affected
- Occupation groups selectively affected
-
- none selectively affected
ICD & OMIM codes
- ICD-9
-
- Temporal lobe epilepsy: 345.4
- ICD-10
-
- Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures: G40.2
This is an article preview.
Start a Free Account
to access the full version.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Questions or Comment?
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Also in This Category
-
-
Epilepsy & Seizures
Photosensitive occipital lobe epilepsy
Dec. 03, 2024
-
General Child Neurology
Breath-holding spells
Nov. 25, 2024
-
Epilepsy & Seizures
Intermittent explosive disorder
Nov. 11, 2024
-
General Child Neurology
Acute cerebellar ataxia in children
Oct. 29, 2024
-
Headache & Pain
Headache in children: overview and treatment approaches
Oct. 29, 2024
-
Headache & Pain
Alternating hemiplegia of childhood
Oct. 29, 2024
-
Epilepsy & Seizures
Pyridoxine/P5P-dependent developmental epileptic encephalopathy
Oct. 14, 2024